Stay updated on Pembrolizumab in MSI Tumors Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in MSI Tumors Clinical Trial page.

Latest updates to the Pembrolizumab in MSI Tumors Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page history shows a new revision (v3.4.2) and removal of the previous revision (v3.4.1), indicating a minor platform update with no visible changes to study data or content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check20 days agoChange DetectedA new revision tag, v3.4.1, was added to the history, replacing v3.4.0, which is a minor update with no changes to study data or user-facing features. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check27 days agoChange DetectedNon-significant UI updates include showing the glossary option, color-coded change indicators and revision labeling (v3.4.0 replacing v3.3.4). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check42 days agoChange DetectedAdded Revision: v3.3.4 to the record history. Removed Revision: v3.3.3.SummaryDifference0.1%

- Check63 days agoChange DetectedA new revision entry, Revision: v3.3.3, was added to the record history. The HHS Vulnerability Disclosure and Revision: v3.3.2 elements were removed from the footer; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check92 days agoChange DetectedAdded Revision: v3.3.2; Removed Revision: v3.2.0 from the history.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in MSI Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in MSI Tumors Clinical Trial page.